| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $65,804 | 2 | 5 |
Sells | $11,110,628 | 37 | 95 |
| GAYNOR RICHARD | director | 2 | $65,804 | 0 | $0 | $65,804 |
| Chen Yajing | Chief Financial Officer | 0 | $0 | 7 | $223,639 | $-223,639 |
| Smiley Joshua L | See Remarks | 0 | $0 | 3 | $294,344 | $-294,344 |
| Lis William | director | 0 | $0 | 2 | $340,004 | $-340,004 |
| Amado Rafael | See Remarks | 0 | $0 | 5 | $674,994 | $-674,994 |
| Edmondson Frazor Titus III | Chief Legal Officer | 0 | $0 | 8 | $1.01M | $-1.01M |
| Du Ying | Chairperson & CEO | 0 | $0 | 13 | $8.58M | $-8.58M |
Operating primarily in Mainland China and Hong Kong, Zai Lab Limited is a biopharmaceutical company focused on the discovery, development, and commercialization of innovative medical treatments. Their therapeutic portfolio spans oncology, autoimmune conditions, infectious diseases, and neurological disorders. Currently available products in their portfolio include Zejula, a once-daily small-molecule PARP 1/2 inhibitor; Optune, a medical device leveraging tumor treating fields; NUZYRA, an antimicrobial agent for specific acute bacterial skin and …
Over the last 12 months, insiders at Zai Lab Limited have bought $65,804 and sold $11.11M worth of Zai Lab Limited stock.
On average, over the past 5 years, insiders at Zai Lab Limited have bought $255,321 and sold $7.94M worth of stock each year.
Highest buying activity among insiders over the last 12 months: GAYNOR RICHARD (director) — $65,804.
The last purchase of 1,736 shares for transaction amount of $33,071 was made by GAYNOR RICHARD (director) on 2026‑07‑01.
| 2026-08-19 | Sale | Chen Yajing | Chief Financial Officer | 260 0.0002% | $27.00 | $7,020 | -6.14% | |
| 2026-08-12 | Sale | Lis William | director | 8,506 0.0074% | $25.00 | $212,650 | -0.73% | |
| 2026-08-11 | Sale | Chen Yajing | Chief Financial Officer | 619 0.0005% | $25.00 | $15,475 | -2.65% | |
| 2026-07-01 | GAYNOR RICHARD | director | 1,736 0.0015% | $19.05 | $33,071 | +27.05% | ||
| 2026-06-30 | Sale | Du Ying | Chairperson & CEO | 7,026 0.0061% | $18.53 | $130,220 | +27.71% | |
| 2026-06-26 | Sale | Du Ying | Chairperson & CEO | 24,543 0.0211% | $17.46 | $428,545 | +34.36% | |
| 2026-06-26 | Sale | Chen Yajing | Chief Financial Officer | 2,264 0.0019% | $17.46 | $39,532 | +34.36% | |
| 2026-06-26 | Sale | Edmondson Frazor Titus III | Chief Legal Officer | 4,103 0.0035% | $17.46 | $71,642 | +34.36% | |
| 2026-06-22 | Sale | Lis William | director | 7,040 0.0061% | $18.09 | $127,354 | +30.41% | |
| 2026-05-18 | Sale | Du Ying | Chairperson & CEO | 50,000 0.0455% | $19.00 | $949,765 | +17.02% | |
| 2026-05-15 | Sale | Du Ying | Chairperson & CEO | 50,000 0.0455% | $20.74 | $1.04M | +7.12% | |
| 2026-05-14 | Sale | Du Ying | Chairperson & CEO | 50,000 0.0446% | $20.09 | $1M | +8.41% | |
| 2026-05-14 | Sale | Edmondson Frazor Titus III | Chief Legal Officer | 3,517 0.0032% | $20.19 | $71,008 | +8.41% | |
| 2026-05-13 | Sale | Du Ying | Chairperson & CEO | 50,000 0.0441% | $19.97 | $998,469 | +7.47% | |
| 2026-04-06 | Sale | Du Ying | Chairperson & CEO | 2,653 0.0024% | $20.45 | $54,249 | +5.56% | |
| 2026-04-06 | Sale | Smiley Joshua L | See Remarks | 3,017 0.0027% | $20.45 | $61,692 | +5.56% | |
| 2026-04-06 | Sale | Amado Rafael | See Remarks | 2,739 0.0025% | $20.45 | $56,007 | +5.56% | |
| 2026-04-06 | Sale | Chen Yajing | Chief Financial Officer | 853 0.0008% | $20.45 | $17,442 | +5.56% | |
| 2026-04-06 | Sale | Edmondson Frazor Titus III | Chief Legal Officer | 1,224 0.0011% | $20.45 | $25,028 | +5.56% | |
| 2026-04-02 | Sale | Du Ying | Chairperson & CEO | 5,576 0.0051% | $20.39 | $113,695 | +5.78% |
| Smiley Joshua L | See Remarks | 117602 0.1043% | $2.58M | 5 | 8 | <0.0001% |
| GAYNOR RICHARD | director | 80737 0.0716% | $1.77M | 2 | 1 | |
| WIRTH PETER | director | 0 0% | $0 | 1 | 1 | <0.0001% |
$52,263,649 | 70 | 1.18% | $2.49B | |
$586,486,795 | 47 | 4.28% | $2.38B | |
$154,047,855 | 36 | 79.21% | $2.21B | |
$28,907,358 | 35 | 41.41% | $2.28B | |
$1,603,489 | 30 | 98.90% | $2.33B |
| Increased Positions | 72 | +38.92% | 11M | +32.43% |
| Decreased Positions | 84 | -45.41% | 17M | -49.69% |
| New Positions | 33 | New | 2M | New |
| Sold Out Positions | 44 | Sold Out | 10M | Sold Out |
| Total Postitions | 173 | -6.49% | 29M | -17.26% |
| Capital World Investors | $105,326.00 | 5.43% | 6.08M | +41,481 | +0.69% | 2025-09-30 |
| Fmr Llc | $81,481.00 | 4.2% | 4.7M | -1M | -24.13% | 2025-09-30 |
| Clearbridge Investments, Llc | $60,990.00 | 3.14% | 3.52M | -492,619 | -12.28% | 2025-09-30 |
| Rtw Investments, Lp | $39,709.00 | 2.05% | 2.29M | -3M | -58.62% | 2025-09-30 |
| Janus Henderson Group Plc | $35,518.00 | 1.83% | 2.05M | -148,323 | -6.75% | 2025-09-30 |
| Wellington Management Group Llp | $29,781.00 | 1.53% | 1.72M | +341,492 | +24.8% | 2025-09-30 |
| Frazier Life Sciences Management, L.P. | $28,201.00 | 1.45% | 1.63M | +319,182 | +24.4% | 2025-09-30 |
| Bamco Inc /Ny/ | $23,764.00 | 1.22% | 1.37M | -216,571 | -13.64% | 2025-09-30 |
| Citadel Advisors Llc | $17,105.00 | 0.88% | 987,043 | +620,830 | +169.53% | 2025-09-30 |
| Price T Rowe Associates Inc /Md/ | $16,440.00 | 0.85% | 948,671 | +795,634 | +519.9% | 2025-09-30 |